Mr Richard Kerr qualified from The London Hospital, and trained in surgery and neurosurgery in London, Oxford and Melbourne. Based at the John Radcliffe Hospital in Oxford, he has been consultant for 30years. With a wide cranial and spinal practice, he has subspecialty interests in skull base tumours, oncology and vascular disease. He devised and runs the Oxford Skull Base Practice and is a member of the NFII clinic, a nationally co-ordinated regional service. Research has led to publication of over 40 peer reviewed articles and 15 book chapters. He was Co-Principal Investigator in the MRC funded International Subarachnoid Aneurysm Trial (ISAT). The publication of this trial has led to a global change in the management of aneurysmal subarachnoid haemorrhage, with invitations to speak to learned societies from all over the world. Active in management, and trained as a civil and commercial mediator, he has been Lead Clinician of the Neurosurgical Department, Clinical Centre Chairman of the Radcliffe Infirmary and Chairman of the Relocation Steering Committee of Services to the John Radcliffe Hospital. Elected to the Council of the Society of British Neurological Surgeons (SBNS) in 2003, he was appointed Treasurer of the SBNS in 2010 and Member of the Neurosurgical SAC in 2011. He is President-Elect of the SBNS, taking up office of President of the SBNS from September 2014-2016. With interests in co-operation between the specialist surgical associations, audit and surgical outcome data, he was elected to council of The Royal College of Surgeons of England in 2013, and was re-elected in 2019 having served as Trustee from 2015-2017. He chaired the independent commission on the Future of Surgery, published in December 2019.
Professor Tiit Mathiesen was a neurosurgeon at the Karolinska Institute in Sweden prior to receiving his chair as professor at the University of Coenhagen in Denmark. He has a remarkable expertise in the care of patients with meningioma and skull base surgery. This, coupled with a significant contribution to meningioma research, enables him to provide a unique insight into their care and treatment. He has published over 200 articles and authored numerous book chapters in neurosurgery. He is the Chairman of the WFNS ethics committee and is editor-in-chief of the major European neurosurgery journal, Acta Neurochirurgica.
Michel Kalamarides is a Professor of Neurosurgery at Pitié-Salpetrière Hôpital (Faculté de Medécine, Sorbonne- Université), Paris France. He is specialized in vestibular schwannoma and meningioma surgery. Within a large INSERM unit- U 1127 at Brain and Spine Institute (Pitié-Salpetrière), he is leading a research group on meningioma, particularly using mouse models to dissect the mechanisms of meningioma initiation and progression. He is leading the French NF2 reference clinical center and the French NF2 network.
Michael Jenkinson is a Reader in Neurosurgery and Honorary consultant neurosurgeon at the University of Liverpool and Walton Centre NHS Foundation Trust. He sub-specialises in neurosurgical oncology including awake craniotomy, intraventricular / pineal tumours and stereotactic radiosurgery. He chairs the National Cancer Research Institute brain tumour Clinical Studies Group, as well as being a member of the Society of British Neurological Surgeons academic committee and The Brain Tumour Charity Quality of Life Scientific Advisory Board. His research interests include meningioma and cerebral metastasis, and clinical studies on quality of life in brain tumours. He is the recipient of grants for basic science and clinical research from the MRC, NIHR and Industry, including as chief investigator for the international, multi-centre ROAM-1308 trial (Radiation versus Observation following surgical resection of Atypical Meningioma) and the KEATING trial (Ketogenic Diet in Glioma).
Mr Thomas Santarius is a Consultant Neurosurgeon practicing at the Addenbrooke’s Hospital in Cambridge, UK. He specialises in brain tumour surgery in adults, but also in children. Mr Santarius has completed his neurosurgical training in Cambridge with additional sub-specialist experience in other neurosurgery centres in the UK, France and the USA. His clinical, teaching and research efforts are focused on better understanding of surgical anatomy, perfecting surgical techniques, advancing our knowledge of the biology of brain tumours, especially meningioma, and is committed to constantly improving the way we manage patients with brain tumours. He is the Chair of the Meningioma and Metastasis Subgroup of the National Cancer Research Institute and the current President of the British-Irish Meningioma Society.
Mr Jeyaretna is the Lead Neurosurgeon for the Oxford University Hospitals Skull Base Surgery Programme. He graduated from the University of Southampton and underwent registrar and skull base surgery training at Frenchay Hospital in Bristol. His clinical practice focuses on the surgical treatment of complex skull base lesions with open and endoscopic techniques. He co-delivers the radiosurgery service at Oxford with his radiation oncology colleagues. He completed post-doctoral research at Massachusetts General Hospital and Harvard Medical School with an interest in tumour biology. He continues to collaborate with scientists at Oxford University on translational research models of brain tumours. His current research interests are in developing and integrating artificial intelligence technology into the skull base surgery service at Oxford. He has a strong interest in the training of the next generation of surgeons and is the Training Programme Director for the Oxford Programme and Co-Director of the Oxford Skull Base Surgery and Neurovascular Fellowship. Mr Jeyaretna is regular faculty on skull base surgery dissection courses internationally including the World Federation of Neurosurgical Societies, Royal College of Surgeons England and Director of the Oxford Skull Base Course.
Jonathan Pollock graduated from Cambridge University and the John Radcliffe Hospital, Oxford. His Neurosurgical training was in Oxford , Nottingham and London. He has been Consultant Neurosurgeon at Essex Neurosciences Centre since 2002. He is Skull Base lead with a particular interest in Meningioma , of which he has treated over 500 as a consultant. His focus is on improving operative technique with multidisciplinary care , and on gaining a better understanding of prognosis in meningioma. The Essex team hosts an RCS Skull Base Fellowship. He is a former Clinical Director and is currently the lead for Neuro-Oncology . He has served on the SAC, and is a member of the JCST Question Writing Group and the National Selection panel . He is the Hon Treasurer of BIMS.
Mr Kirollos graduated from the Medical School at the University of Alexandria in Egypt in 1984. In 1987 he moved to the United Kingdom to pursue his post-graduate medical education. He received the prestigeous Royal College of Surgeons of England Hallett Prize given to the candidate with the highest score at the membership examination (FRCS Eng). Mr Kirollos trained in neurosurgery at the Atkinson Morley Hospital in London, the Frenchay Hospital in Bristol, the Leeds General Infirmary, and the Walton Centre for Neurology and Neurosurgery in Liverpool. He obtained an MD degree for his research into photodynamic therapy of pituitary adenomas. Mr Kirollos completed a skull base fellowship under Dr Gentili at the Toronto Western Hospital. In 2001 he was appointed Consultant Neurosurgeon at the Addenbrooke’s Hospital in Cambridge. His main clinical interests include anterior and middle skull base, pituitary and pineal surgery, and surgical treatment of AVMs. Mr Kirollos serves as a faculty on the Neuroanatomy of Operative Approaches and the British Neurosurgical Trainee Courses since their conception in 2005 and 2010, respectively. In 2006 Mr Kirollos was elected as a member of the Court of Examiners of the Royal College of Surgeons of England. For his commitment to surgical education he received the prestigious Silver Scalpel Award in 2010.
Dr Michael McDermott is co-director of the Gamma Knife and CyberKnife Radiosurgery Program at UCSF Medical Center. He cares for patients with a wide range of conditions, including brain tumors, neurological cancers, central nervous system infections and hydrocephalus. His specialty is stereotactic neurosurgery, such as Gamma Knife radiosurgery, in particular for tumors of the central nervous system, meningiomas and skull base conditions. Dr McDermott earned his medical degree cum laude from the University of Toronto. After completing a residency in neurosurgery at the University of British Columbia, he was awarded a research fellowship in neuro-oncology from the UCSF Brain Tumor Research Center.
Dr Magill is a senior neurosurgery resident at UCSF in USA and has a research interest in the development of a molecular diagnostic and prognostic signatures for meningioma.
Dr David Raleigh is an assistant professor in the Department of Radiation Oncology at UCSF and specialises in the treatment and investigation of central nervous system tumors in adult and pediatric patients.